Cargando…

48. TOPICAL CAPTOPRIL: A PROMISING THERAPEUTIC AVENUE FOR LYMPHEDEMA TREATMENT

Detalles Bibliográficos
Autores principales:	Brown, Stav, Li, Claire, Ly, Catherine, Gabriela, García Nores, Gardenier, Jason, Aras, Omer, Baik, Jungeun, Kataru, Raghu, Mehrara, Babak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984399/ http://dx.doi.org/10.1097/01.GOX.0000828180.27566.fd

Ejemplares similares

Abstract 1: Topical Tacrolimus for the Treatment of Lymphedema
por: Gardenier, Jason C., et al.
Publicado: (2017)

Topical tacrolimus for the treatment of secondary lymphedema
por: Gardenier, Jason C., et al.
Publicado: (2017)

Abstract 9: Th2 Deficiency Attenuates The Pathologic Findings Of Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2017)

Inflammatory Manifestations of Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2017)

20. Skin Barrier Dysfunction in Lymphedema
por: Campbell, Adana, et al.
Publicado: (2023)

Lymph Node Transplantation Decreases Swelling and Restores Immune Responses in a Transgenic Model of Lymphedema
por: Huang, Jung-Ju, et al.
Publicado: (2016)

Abstract 120: Lymph Node Transplantation Decreases Local Immunosuppression In Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2018)

154. Non-invasive Detection of Subclinical Skin Changes in Lymphedema: A Promising Screening Method for Early Stage Disease
por: Brown, Stav, et al.
Publicado: (2023)

Doxycycline for the treatment of breast cancer-related lymphedema
por: Brown, Stav, et al.
Publicado: (2022)

PC32. Non-invasive Detection of Subclinical Skin Changes in Lymphedema: A Promising Screening Method for Early Stage Disease
por: Brown, Stav, et al.
Publicado: (2023)

Histopathologic Features of Lymphedema: A Molecular Review
por: Li, Claire Y., et al.
Publicado: (2020)

Pharmacological Treatment of Secondary Lymphedema
por: Brown, Stav, et al.
Publicado: (2022)

Skin microbiome alterations in upper extremity secondary lymphedema
por: Campbell, Adana-Christine, et al.
Publicado: (2023)

CD4(+) T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema
por: García Nores, Gabriela D., et al.
Publicado: (2018)

Regulation of Immune Function by the Lymphatic System in Lymphedema
por: Kataru, Raghu P., et al.
Publicado: (2019)

The Future of Lymphedema: Potential Therapeutic Targets for Treatment
por: Brown, Stav, et al.
Publicado: (2023)

148. Extravasated Lymph from Secondary Lymphedema Patients Increases Cellular Permeability and Decreases Lymphatic Endothelial Cell VEGFR3 Expression
por: Kuonqui, Kevin, et al.
Publicado: (2023)

Lymphatics in Tumor Progression and Immunomodulation
por: Li, Claire Y., et al.
Publicado: (2022)

Secondary Lymphedema: Autoimmune, Auto-inflammatory, or Both?
por: Campbell, Adana, et al.
Publicado: (2023)

Th2 Cytokines Inhibit Lymphangiogenesis
por: Savetsky, Ira L., et al.
Publicado: (2015)

Structural and Functional Changes in Aged Skin Lymphatic Vessels
por: Kataru, Raghu P., et al.
Publicado: (2022)

The Association between Lymphedema and Autoimmunity: A Large Case Control Study
por: Brown, Stav, et al.
Publicado: (2023)

155. Lymphedema and Autoimmunity: Is There A Link?
por: Brown, Stav, et al.
Publicado: (2023)

D8. Lymphedema and Autoimmunity: Is There a Link?
por: Brown, Stav, et al.
Publicado: (2023)

Doxycycline for the Treatment of Cancer-related Lymphedema
por: Brown, Stav, et al.
Publicado: (2022)

TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
por: Baik, Jung Eun, et al.
Publicado: (2022)

Inhibition of Inflammation and iNOS Improves Lymphatic Function in Obesity
por: Torrisi, Jeremy S., et al.
Publicado: (2016)

29. Natural History of Breast Cancer-related Lymphedema
por: Brown, Stav, et al.
Publicado: (2023)

Prospective, Longitudinal Study of the Natural History of Breast Cancer-related Lymphedema and Factors Predictive of Disease Progression
por: Brown, Stav, et al.
Publicado: (2023)

Exercise training improves obesity‐related lymphatic dysfunction
por: Hespe, Geoffrey E., et al.
Publicado: (2016)

Lymphatic function regulates contact hypersensitivity dermatitis in obesity
por: Savetsky, Ira L., et al.
Publicado: (2015)

145. Prolonged Exposure to VEGF-C Induces Resistance to Subsequent Stimulation of VEGFR3 in Lymphatic Endothelial Cells
por: Kuonqui, Kevin, et al.
Publicado: (2023)

Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema
por: Mehrara, Babak J., et al.
Publicado: (2021)

43. A Decade of Vascularized Lymph Node Transplant (VLNT) for the Treatment of Lymphedema: A Meta-analysis of Prospective Clinical Trials
por: Brown, Tal, et al.
Publicado: (2023)

Regulation of Lymphatic Function in Obesity
por: Kataru, Raghu P., et al.
Publicado: (2020)

Regulation of lymphatic function and injury by nitrosative stress in obese mice
por: Rehal, Sonia, et al.
Publicado: (2020)

2. LONG-TERM PROSPECTIVE SAFETY AND EFFICACY OF VASCULARIZED LYMPH NODE TRANSPLANT (VLNT)
por: Brown, Stav, et al.
Publicado: (2022)

Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes
por: Li, Claire Y., et al.
Publicado: (2022)

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
por: Szőke, Dániel, et al.
Publicado: (2021)

Obesity but not high-fat diet impairs lymphatic function
por: García Nores, G D, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9c6mm73l6ipdmfj8pg4lbtl1qb